IceCure Medical (ICCM) vs INVO Fertility (IVF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
IceCure Medical is the larger company by market cap ($5.1 million vs $3.3 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICCM | IVF |
|---|---|---|
| Share price | $1.10 | $0.7275 |
| Market cap | $5.10M | $3.35M |
| 1-day change | -3.08% | -2.28% |
| P/E ratio (TTM) | — | 0.01 |
| EPS (TTM) | $-6.84 | $127.95 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $29.46 | $84.40 |
| 52-week low | $1.04 | $0.71 |
| Distance from 52-week high | -96.27% | -99.14% |
| Analyst consensus | none | none |
| Avg. price target upside | +1960.91% | +2649.14% |
| Average volume | 139.00K | 2.16M |
| Shares outstanding | 4.64M | 4.60M |
| Employees | 67 | 40 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About IceCure Medical
ICCM stock →IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Health Care · Medical/Dental Instruments · 67 employees
About INVO Fertility
IVF stock →INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments.
Health Care · Medical/Dental Instruments · 40 employees
ICCM vs IVF FAQ
Which is bigger, IceCure Medical or INVO Fertility?
IceCure Medical (ICCM) is larger, with a market capitalization of $5.10M compared with $3.35M for INVO Fertility (IVF).
Are IceCure Medical and INVO Fertility in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.